Human SLE is an autoimmune disease characterized by the production of autoantibodies against nuclear and cytoplasmic antigens, accompanied by complement activation, dramatic longitudinal fluctuations in serum C4 and C3 levels, and immune-mediated tissue damage [42]. The gene discussed is C4A; the disease is systemic lupus erythematosus.